Literature DB >> 21995570

The split personality of NKT cells in malignancy, autoimmune and allergic disorders.

Jeff J Subleski1, Qun Jiang, Jonathan M Weiss, Robert H Wiltrout.   

Abstract

NKT cells are a heterogeneous subset of specialized, self-reactive T cells, with innate and adaptive immune properties, which allow them to bridge innate and adaptive immunity and profoundly influence autoimmune and malignant disease outcomes. NKT cells mediate these activities through their ability to rapidly express pro- and anti-inflammatory cytokines that influence the type and magnitude of the immune response. Not only do NKT cells regulate the functions of other cell types, but experimental evidence has found NKT cell subsets can modulate the functions of other NKT subsets. Depending on underlying mechanisms, NKT cells can inhibit or exacerbate autoimmunity and malignancy, making them potential targets for disease intervention. NKT cells can respond to foreign and endogenous antigenic glycolipid signals that are expressed during pathogenic invasion or ongoing inflammation, respectively, allowing them to rapidly react to and influence a broad array of diseases. In this article we review the unique development and activation pathways of NKT cells and focus on how these attributes augment or exacerbate autoimmune disorders and malignancy. We also examine the growing evidence that NKT cells are involved in liver inflammatory conditions that can contribute to the development of malignancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21995570      PMCID: PMC3230042          DOI: 10.2217/imt.11.117

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  211 in total

1.  Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice.

Authors:  G Eberl; B Lowin-Kropf; H R MacDonald
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

2.  NKT cells derive from double-positive thymocytes that are positively selected by CD1d.

Authors:  L Gapin; J L Matsuda; C D Surh; M Kronenberg
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

3.  Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide.

Authors:  I Toura; T Kawano; Y Akutsu; T Nakayama; T Ochiai; M Taniguchi
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

4.  Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage.

Authors:  H J van der Vliet; B M von Blomberg; N Nishi; M Reijm; A E Voskuyl; A A van Bodegraven; C H Polman; T Rustemeyer; P Lips; A J van den Eertwegh; G Giaccone; R J Scheper; H M Pinedo
Journal:  Clin Immunol       Date:  2001-08       Impact factor: 3.969

5.  Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

Authors:  S M Tahir; O Cheng; A Shaulov; Y Koezuka; G J Bubley; S B Wilson; S P Balk; M A Exley
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

6.  A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.

Authors:  K Miyamoto; S Miyake; T Yamamura
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

7.  Diverse TCRs recognize murine CD1.

Authors:  S M Behar; T A Podrebarac; C J Roy; C R Wang; M B Brenner
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

8.  CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.

Authors:  B Wang; Y B Geng; C R Wang
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

9.  The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.

Authors:  H Kitamura; K Iwakabe; T Yahata; S Nishimura; A Ohta; Y Ohmi; M Sato; K Takeda; K Okumura; L Van Kaer; T Kawano; M Taniguchi; T Nishimura
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

10.  Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells.

Authors:  J Cui; N Watanabe; T Kawano; M Yamashita; T Kamata; C Shimizu; M Kimura; E Shimizu; J Koike; H Koseki; Y Tanaka; M Taniguchi; T Nakayama
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

View more
  20 in total

Review 1.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

Review 2.  Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections.

Authors:  Jimmy K Stauffer; Anthony J Scarzello; Qun Jiang; Robert H Wiltrout
Journal:  Hepatology       Date:  2012-09-11       Impact factor: 17.425

3.  Expression of blood serum proteins and lymphocyte differentiation clusters after chronic occupational exposure to ionizing radiation.

Authors:  Valentina L Rybkina; Tamara V Azizova; Harry Scherthan; Viktor Meineke; Harald Doerr; Galina V Adamova; Olga V Teplyakova; Sergey V Osovets; Maria V Bannikova; Alexander V Zurochka
Journal:  Radiat Environ Biophys       Date:  2014-07-30       Impact factor: 1.925

4.  Applying the uncertainty principle to immunology.

Authors:  Ena Wang; Francesco M Marincola
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

Review 5.  Cell mediators of autoimmune hepatitis and their therapeutic implications.

Authors:  Aldo J Montano-Loza; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

6.  A role for Ly108 in the induction of promyelocytic zinc finger transcription factor in developing thymocytes.

Authors:  Mala Dutta; Zachary J Kraus; Julio Gomez-Rodriguez; Sun-Hee Hwang; Jennifer L Cannons; Jun Cheng; Sang-Yun Lee; David L Wiest; Edward K Wakeland; Pamela L Schwartzberg
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

7.  STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis.

Authors:  Abhirami K Iyer; Jianyun Liu; Richard M Gallo; Mark H Kaplan; Randy R Brutkiewicz
Journal:  Immunology       Date:  2015-09-21       Impact factor: 7.397

8.  Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis.

Authors:  Jennifer E Snyder-Cappione; Douglas F Nixon; Joyce C Chi; Michelle-Linh T Nguyen; Christopher K Kirby; Jeffrey M Milush; Laura L Koth
Journal:  Eur J Immunol       Date:  2013-06-25       Impact factor: 5.532

9.  Exploring the functions of nonclassical MHC class Ib genes in Xenopus laevis by the CRISPR/Cas9 system.

Authors:  Maureen Banach; Eva-Stina Edholm; Jacques Robert
Journal:  Dev Biol       Date:  2016-06-16       Impact factor: 3.582

10.  Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine.

Authors:  L Loh; M A Ivarsson; J Michaëlsson; J K Sandberg; D F Nixon
Journal:  Mucosal Immunol       Date:  2014-03-19       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.